Previous close | N/A |
Open | N/A |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | N/A - N/A |
52-week range | 39.17 - 39.17 |
Volume | |
Avg. volume | 5 |
Market cap | 15.215B |
Beta (5Y monthly) | 0.89 |
PE ratio (TTM) | 14.89 |
EPS (TTM) | 2.55 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
REGULATED INFORMATION MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Article 223-16 of the AMF General Regulation Date Shares Voting rights Theoretical (1) Exercisable (2) 30 November 2023 381,899,215 501,487,552 497,475,971 (1) In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all the shares to which voting rights are attached, including shares for which voting rights have been suspended.(2) For information purposes on
REGULATED INFORMATION DISCLOSURE OF TRADING IN OWN SHARES Paris, 20/11/2023 Disclosure of trading in own shares on 13, 14, and 15 November 2023.As part of the authorisation granted by the Annual General Meeting of 27 April 2023 I. Summary presentation Name of issuer Identity code of issuer Transaction date Identity code of financial instrument Total daily volume traded (number of shares) Daily weighted average price of shares purchased Market BOUYGUES SA 969500MOCLNQFNZN0D63 13 november 2023 FR0
Press release Paris, 31/10/2023 NINE-MONTH 2023 RESULTS Solid set of nine-month 2023 Group results, and marked by Equans’ contribution Group sales up 38% year-on-year and up 3% versus the nine-month 2022 proforma figure including Equans1Group current operating profit from activities up €383m year-on-year and €237m versus the nine-month 2022 proforma figure including Equans1 Group net debt at end-September 2023 stood at €10.2bnThe Group confirms its outlook for 2023Market environment remains chal